Immunophenotypes of Ductal Epithelial Cells in Advanced Pancreatic Ductal Adenocarcinoma

被引:19
|
作者
Zhou, Rui [1 ]
Xu, Xiaoxiao [2 ]
Liu, Meizhen [3 ]
Wu, Xinmou [3 ]
Li, Rong [2 ]
机构
[1] Guangxi Med Univ, Dept Hepatobiliary Surg, Guigang City Peoples Hosp, Affiliated Hosp 8, Guigang, Peoples R China
[2] Guilin Med Univ, Key Lab Tumor Immunol & Microenvironm Regulat, Huan Cheng North 2nd Rd 109, Guilin 541004, Peoples R China
[3] Guangxi Med Univ, Coll Pharm, Nanning, Peoples R China
基金
中国国家自然科学基金;
关键词
Pancreatic ductal adenocarcinoma; Ductal cells; Biomarker; Ubiquitination; DIFFERENTIATION; ACID;
D O I
10.1159/000492861
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: In this report, we aimed to investigate the distribution and characterization of biomarker-immunolabeled ductal epithelium in advanced pancreatic ductal adenocarcinoma (PDAC). Design: Eighteen patients with PDAC were medically diagnosed prior to being treated periodically. All clinical records were collected and assayed. The PDAC samples were subjected to routine biochemical tests and immuno-stains of immunohistochemistry and immunofluorescence. Results: As results, immunohistochemical findings indicated pancreatic ductal cells in PDAC showed plenty of Ki-67, P53, RP, SAM positive cells expressed in nuclei. In addition, ductal epithelial cells exhibited numerous positive cells of CK7, 18, 19, 20 biomarkers, respectively. Interestingly, compared to non-PDAC controls, immunostaining results showed that endocrine hormones were positively expressed in pancreatic ducts of PDAC, characterized with increased insulin-, Ngn3-, PDX1-fluorescence-labeled cells, and reduced F-box and WD-40 domain protein 7 (Fbxw7)-labeled cells in ducts. Conclusion: These clinicopathologic findings preliminarily disclose that there may be a potential for insulin- producing cells in PDAC, possibly through negatively inducing Fbxw7 ubiquitination in pancreatic ducts. (C) 2018 S. Karger AG, Basel
引用
收藏
页码:247 / 251
页数:5
相关论文
共 50 条
  • [1] Immunophenotypes of pancreatic ductal adenocarcinoma: Meta-analysis of transcriptional subtypes
    de Santiago, Ines
    Yau, Christopher
    Heij, Lara
    Middleton, Mark R.
    Markowetz, Florian
    Grabsch, Heike, I
    Dustin, Michael L.
    Sivakumar, Shivan
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (04) : 1125 - 1137
  • [2] RESTRAINING PANCREATIC DUCTAL ADENOCARCINOMA PROGRESSION WITH CHOP DEPLETION IN PANCREATIC EPITHELIAL CELLS
    Muranaka, Hayato
    Yong, Jing
    Waldron, Richard T.
    Aquino, Albert-Fred
    Jang, Insook
    Kaufman, Randal J.
    Pandol, Stephen J.
    Lugea, Aurelia
    GASTROENTEROLOGY, 2024, 166 (05) : S241 - S241
  • [3] Mast cells in pancreatic ductal adenocarcinoma
    Chang, David Z.
    ONCOIMMUNOLOGY, 2012, 1 (05): : 754 - 755
  • [4] Treatment of Locally Advanced Pancreatic Ductal Adenocarcinoma
    Loehrer, Andrew P.
    Ferrone, Cristina R.
    DIGESTIVE SURGERY, 2016, 33 (04) : 343 - 350
  • [5] Advanced Pancreatic Ductal Adenocarcinoma: Moving Forward
    Franck, Caspar
    Mueller, Christian
    Rosania, Rosa
    Croner, Roland S.
    Pech, Maciej
    Venerito, Marino
    CANCERS, 2020, 12 (07) : 1 - 19
  • [6] Radiotherapy for locally advanced pancreatic ductal adenocarcinoma
    Buss, Elizabeth J.
    Kachnic, Lisa A.
    Horowitz, David P.
    SEMINARS IN ONCOLOGY, 2021, 48 (01) : 106 - 110
  • [7] Evaluation of epithelial and stromal component in pancreatic ductal adenocarcinoma
    Paklina, O.
    Setdikova, G.
    Rotin, D.
    VIRCHOWS ARCHIV, 2014, 465 : S302 - S302
  • [8] Pancreatic ductal adenocarcinoma
    Gallmeier, E.
    Gress, T. M.
    INTERNIST, 2018, 59 (08): : 805 - 822
  • [9] Pancreatic Ductal Adenocarcinoma
    Heinemann, V.
    Schmidberger, H.
    ONKOLOGE, 2019, 25 (08): : 642 - 644
  • [10] Pancreatic ductal adenocarcinoma
    Gallmeier, E.
    Gress, T. M.
    GASTROENTEROLOGE, 2019, 14 (02): : 131 - 148